A novel anticancer agent, consisting of a monoclonal antibody linked to a chemotherapy drug, showed substantial anti-tumor activity in ovarian cancer cell lines and in mice, according to a new study.
A novel anticancer agent, consisting of a monoclonal antibody linked to a chemotherapy drug, showed substantial anti-tumor activity in ovarian cancer cell lines and in mice, according to a new study.